v3.26.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in capital
Unallocated Common Stock Held by ESOP
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2024 $ 396,088 $ 81 $ 168,138 $ (1,339) $ 259,190 $ (29,982)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 34,651       34,651  
Other comprehensive income (loss) 10,091         10,091
Purchase of Company’s common stock at cost (14,313) (3) (3,206)   (11,104)  
Cash dividends declared (6,562)       (6,562)  
Common stock issued under incentive plans, net of shares surrendered in payment, including tax benefit 608   871   (263)  
Exercise of stock options 38   38      
ESOP shares released for allocation 1,454   1,186 268    
Share-based compensation cost 989   989      
Ending balance at Sep. 30, 2025 423,044 78 168,016 (1,071) 275,912 (19,891)
Beginning balance at Jun. 30, 2025 408,818 78 166,576 (1,160) 265,817 (22,493)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 12,357       12,357  
Other comprehensive income (loss) 2,602         2,602
Purchase of Company’s common stock at cost 5   (2)   7  
Cash dividends declared (2,269)       (2,269)  
Common stock issued under incentive plans, net of shares surrendered in payment, including tax benefit 606   606      
ESOP shares released for allocation 528   439 89    
Share-based compensation cost 370   370      
Ending balance at Sep. 30, 2025 423,044 78 168,016 (1,071) 275,912 (19,891)
Beginning balance at Dec. 31, 2025 435,094 78 168,963 (982) 284,834 (17,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 33,072       33,072  
Other comprehensive income (loss) (10,509)         (10,509)
Purchase of Company’s common stock at cost (456)   (74)   (382)  
Cash dividends declared (7,377)       (7,377)  
Common stock issued under incentive plans, net of shares surrendered in payment, including tax benefit 155 1 622   (468)  
Exercise of stock options 11   11      
ESOP shares released for allocation 1,794   1,526 268    
Share-based compensation cost 1,314   1,314      
Ending balance at Sep. 30, 2026 453,098 79 172,362 (714) 309,679 (28,308)
Beginning balance at Jun. 30, 2026 453,457 79 171,234 (803) 302,171 (19,224)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 10,097       10,097  
Other comprehensive income (loss) (9,084)         (9,084)
Purchase of Company’s common stock at cost (25)   (4)   (21)  
Cash dividends declared (2,518)       (2,518)  
Common stock issued under incentive plans, net of shares surrendered in payment, including tax benefit 77   127   (50)  
ESOP shares released for allocation 641   552 89    
Share-based compensation cost 453   453      
Ending balance at Sep. 30, 2026 $ 453,098 $ 79 $ 172,362 $ (714) $ 309,679 $ (28,308)